Keywords
Hypertension
Diabetes Mellitus
Mobile applications
Primary prevention
Cardiovascular prevention
Cross-Sectional Studies
How to Cite
Abstract
Introduction: Cardiovascular disease accounts for 31% of global deaths and 30% of mortality in Colombia. Tolima has the highest mortality rate from ischaemic heart disease (184.9 vs. 155.3 nationally per 100,000 inhabitants), meaning that traditional prevention strategies face accessibility limitations.
Objective: To design an exploratory base in a specialised centre to create a technological tool for the surveillance and prevention of cardiovascular disease in Ibagué 2025.
Methods: cross-sectional study in a specialised centre in Ibagué, 2025. A total of 137 participants (90% CI; 5% error) were selected using non-probabilistic sampling. A validated instrument was developed through systematic review, with five sections.
Results: sample: 68.6% women, 50.4% over 50 years of age. Prevalence of risk factors: hypertension (22.6%), diabetes (19%) and dyslipidaemia (43.1%). 75.2% complied with physical activity recommendations, 8.8% were smokers. 97.8% expressed willingness to use mobile applications for cardiovascular prevention. Preferred functionalities: blood pressure monitoring (29.9%) and medication reminders (28.5%). Main barriers: difficulty of use (51.8%) and lack of functional knowledge (29.2%).
Discussion: This study showed a favourable willingness to use mobile applications for cardiovascular prevention, suggesting a feasible scenario for future research. Limitations: Non-representative sample from a specialised private institution. Instrument with low internal reliability (?<0.40). Results not generalisable to the general population
Conclusions: In this specialised sample, a favourable attitude towards mobile applications (97.8%) was observed, which requires validation with robust instruments and representative sampling.
References
Camacho S, Maldonado N, Bustamante J, Llorente B, Cueto E, Cardona F, Arango C. How much for a broken heart? Costs of cardiovascular disease in Colombia using a person-based approach. PloS one. 2018; 13(12): e0208513. https://doi.org/10.1371/journal.pone.0208513
Gambona Delgado EM, Rojas Sánchez LZ, Bermon Angarita A, Rangel Díaz YA, Jaraba Suárez SJ, Serrano Díaz NC, et al. Cardiovascular risk and its associated factors in health care workers in Colombia: A study protocol. JMIR Res Protoc. 2015; 4(3): e94. https://doi.org/10.2196/resprot.4111
Escobar Díaz GL, Orozco Molina AM, Núñez Montes JR, Muñoz FL. Mortalidad por enfermedades cardiovasculares en Colombia 1993-2017. Un análisis de las políticas públicas. Salud Uninorte. 2020; 36(3): 558-570. https://doi.org/10.14482/sun.36.3.616.12
Joseph P, Lanas F, Roth G, López-Jaramillo P, Lonn E, Miller V, et al. Cardiovascular disease in the Americas: The epidemiology of cardiovascular disease and its risk factors. Lancet Reg. Health - Am. 2025; 42: 100960. https://doi.org/10.1016/j.lana.2024.100960
Lucumí DI, Mentz G, González C, Valenzuela L, Veira M, Tello K. Cardiovascular disease prevention capacity in Colombian local health departments. Glob. Public Health. 2023; 18(1): 2267632. https://doi.org/10.1080/17441692.2023.2267632
Landázuri P, Loango N, Gallego ML. Cardiovascular risk factors in first-degree relatives of patients with hypertension. Colombia Médica. 2011; 42(1):1 7-25. https://doi.org/10.25100/cm.v42i1.747
Patiño-Villada FA, Arango-Vélez EF, Quintero-Velásquez MA, Arenas-Sosa MM. Factores de riesgo cardiovascular en una población urbana de Colombia. Rev. salud pública. 2011; 13: 433-445. https://revistas.unal.edu.co/index.php/revsaludpublica/article/view/15012
Manrique Abril FG, Ospina Díaz JM, Herrera Amaya GM. Prevalencia de factores de riesgo para enfermedades cardiovasculares en Tunja, Colombia. 2007. Investig. andin. 2011; 13: 312-322. https://digitk.areandina.edu.co/entities/publication/2aed8e0e-93a0-434d-b0cc-f0a63c361ee9
Arrubla-Hoyos W, Carrascal-Porras F, Gómez JE. Cardiovascular risk prediction through machine learning: A comparative analysis of techniques. Inycompe. 2024; 26(1), e- 20113229. https://doi.org/10.25100/iyc.v26i1.13229
Komiyama C, Kuwabara M, Harima A, Kanie T, Yamaguchi T, Kodama T. Digital health interventions for atherosclerotic cardiovascular disease: The current impact and future directions for prevention and management. J. Atheroscler. Thromb. 2025; 32(4): 395-404. https://doi.org/10.5551/jat.RV22032
Schwalm JD, Joseph P, Leong D, Lopez-Lopez JP, Onuma O, Bhatt P, et al. Cardiovascular disease in the Americas: optimizing primary and secondary prevention of cardiovascular disease. Lancet Reg. Health - Am. 2025; 42: 100964. https://doi.org/10.1016/j.lana.2024.100964
Nadal C, Sas C, Doherty G. Technology acceptance in mobile health: Scoping review of definitions, models, and measurement. J Med Internet Res. 2020; 22(7): e17256. https://doi.org/10.2196/17256
Davis FD. Perceived usefulness, perceived ease of use, and user acceptance of information technology. MIS Quarterly. 1989; 13(3): 319-340. https://doi.org/10.2307/249008
Rahimi B, Nadri H, Lotfnezhad Afshar H, Timpka T. A systematic review of the technology acceptance model in health informatics. Appl Clin Inform. 2018; 9(3): 604-634. https://doi.org/10.1055/s-0038-1668091
Mishra A, Malik R, Hachiya T, Jürgenson T, Namba S, Posner DC, et al. Stroke genetics informs drug discovery and risk prediction across ancestries. Nature. 2022; 611: 115-123. https://doi.org/10.1038/s41586-022-05165-3
Zuo X, Li X, Tang K, Zhao R, Wu M, Wang Y, et al. Sarcopenia and cardiovascular diseases: A systematic review and meta-analysis. J Cachexia Sarcopenia Muscle. 2023; 14: 1183-1198. https://doi.org/10.1002/jcsm.13221
Katula JA, Dressler EV, Kittel CA, Harvin LN, Almeida FA, Wilson KE, et al. Effects of a digital diabetes prevention program: An RCT. Am J Prev Med. 2022; 62(4): 567-677. https://doi.org/10.1016/j.amepre.2021.10.023
Pagidipati NJ, Nelson AJ, Kaltenbach LA, Leyva M, McGuire DK, Pop-Busui R, et al. Coordinated care to optimize cardiovascular preventive therapies in type 2 diabetes: A randomized clinical trial. JAMA. 2023; 329(15): 1261-1270. https://doi.org/10.1001/jama.2023.2854
Rodríguez-Valadez JM, Tahsin M, Fleischmann KE, Masharani U, Yeboah J, Park M, et al. Cardiovascular and renal benefits of novel diabetes drugs by baseline cardiovascular risk: A systematic review, meta-analysis, and meta-regression. Diabetes Care. 2023; 46(6): 1300-1310. https://doi.org/10.2337/dc22-0772
Zhiting G, Jiaying T, Haiying H, Yuping Z, Qunfei Y, Jingfen J. Cardiovascular disease risk prediction models in the Chinese population- a systematic review and meta-analysis. BMC Public Health. 2022; 22: 1608. https://doi.org/10.1186/s12889-022-13995-z
Chowdhury M, Nevitt S, Eleftheriadou A, Kanagala P, Esa H, Cuthbertson DJ, et al. Cardiac autonomic neuropathy and risk of cardiovascular disease and mortality in type 1 and type 2 diabetes: A meta-analysis. BMJ Open Diabetes Res Care. 2021; 9(2): e002480. https://doi.org/10.1136/bmjdrc-2021-002480
Burton JK, Stewart J, Blair M, Oxley S, Wass A, Taylor-Rowan M, et al. Prevalence and implications of frailty in acute stroke: systematic review & meta-analysis. Age Ageing. 2022; 51(3): afac064. https://doi.org/10.1093/ageing/afac064
Vemulapalli S, Stebbins A, Jones WS, Gutierrez JA, Patel MR, Dolor RJ, et al. Cardiovascular risk and outcomes in symptomatic patients with suspected coronary artery disease and non coronary vascular disease: A report from the Promise trial. Am Heart J. 2021; 242: 82-91. https://doi.org/10.1016/j.ahj.2021.07.010
Singh S, Baars DP, Aggarwal K, Desai R, Singh D, Pinto-Sietsma SJ. Association between lipoprotein (a) and risk of heart failure: A systematic review and meta-analysis of Mendelian randomization studies. Curr Probl Cardiol. 2024; 49(4): 102439. https://doi.org/10.1016/j.cpcardiol.2024.102439
Kariuki JK, Imes CC, Engberg SJ, Scott PW, Klem ML, Cortes YI. Impact of lifestyle-based interventions on absolute cardiovascular disease risk: a systematic review and meta-analysis. JBI Evid Synth. 2024; 22(1): 4-65. https://doi.org/10.11124/JBIES-22-00356
Fatima E, Laila L, Bouqoufi A, Amsdar L, Obtel M. Cardiovascular risk factors in Moroccan women: systematic review and meta-analysis. BMC Public Health. 2024; 24: 2390. https://doi.org/10.1186/s12889-024-19950-4
Borlaug BA, Reddy YNV, Braun A, Sorimachi H, Omar M, Popovic D, et al. Cardiac and metabolic effects of dapagliflozin in heart failure with preserved ejection fraction: The Cameo-Dapa trial. Circulation. 2023; 148(10): 834-844. https://doi.org/10.1161/CIRCULATIONAHA.123.065134
Khani S, Rafiei S, Ghashghaee A, Masoumi M, Rezaee S, Kheradkhah G, et al. Cardiovascular risk factors among nurses: A global systematic review and meta-analysis. Plos One. 2024; 19(3): e0286245. https://doi.org/10.1371/journal.pone.0286245
Martínez-González MA, Montero P, Ruiz-Canela M, Toledo E, Estruch R, Gómez-Gracia E, et al. Yearly attained adherence to Mediterranean diet and incidence of diabetes in a large randomized trial. Cardiovasc Diabetol. 2023;22: 262. https://doi.org/10.1186/s12933-023-01994-2
Towfighi A, Cheng EM, Ayala-Rivera M, Barry F, McCreath H, Ganz DA, et al. Effect of a coordinated community and chronic care model team intervention vs usual care on systolic blood pressure in patients with stroke or transient ischemic attack: The Succeed randomized clinical trial. JAMA Netw Open. 2021; 4(2): e2036227. https://doi.org/10.1001/jamanetworkopen.2020.36227
Liu R, Fan Y, Patel A, Liu H, Du X, Liu B, et al. The association between influenza vaccination, cardiovascular mortality and hospitalization: A living systematic review and prospective meta-analysis. Vaccine. 2024 ;42(5): 1034-1041. https://doi.org/10.1016/j.vaccine.2024.01.040
Fang Z, Zhang Q. Association between cognitive impairment and cardiovascular mortality in mature and older adults: A meta-analysis. Exp Gerontol. 2024; 192: 112440. https://doi.org/10.1016/j.exger.2024.112440
Jo YS, Han S, Lee D, Min KH, Park SJ, Yoon HK, et al. Development of a daily predictive model for the exacerbation of chronic obstructive pulmonary disease. Sci Rep. 2023; 13: 18669. https://doi.org/10.1038/s41598-023-45835-4
Benza RL, Simonneau G, Ghofrani HA, Corris PA, Langleben D, Rosenkranz S, et al. Application of Reveal Lite 2 and Compera 2.0 risk scores to patients with pulmonary arterial hypertension switching to riociguat in the Replace study. J Heart Lung Transplant. 2024; 43(10): 1756-1760. https://doi.org/10.1016/j.healun.2024.06.002
Zhao W, Hu P, Sun W, Wu W, Zhang J, Deng H, et al. Effect of physical activity on the risk of frailty: A systematic review and meta-analysis. Plos One. 2022; 17(12): e0278226. https://doi.org/10.1371/journal.pone.0278226
Turc G, Hadziahmetovic M, Walter S, Churilov L, Larsen K, Grotta JC, et al. Comparison of mobile stroke unit with usual care for acute ischemic stroke management: A systematic review and meta-analysis. JAMA Neurol. 2022; 79(3): 281-290. https://doi.org/10.1001/jamaneurol.2021.5321
Toikumo S, Jennings MV, Pham BK, Lee H, Mallard TT, Bianchi SB, et al. Multi-ancestry meta-analysis of tobacco use disorder identifies 461 potential risk genes and reveals associations with multiple health outcomes. Nat Hum Behav. 2024; 8: 1177-1193. https://doi.org/10.1038/s41562-024-01851-6
Hassen HY, Ndejjo R, Musinguzi G, Van Geertruyden JP, Abrams S, Bastiaens H. Effectiveness of community-based cardiovascular disease prevention interventions to improve physical activity: A systematic review and meta-regression. Prev Med. 2021; 153: 106797. https://doi.org/10.1016/j.ypmed.2021.106797
Xu Y, Meng Y, Qian X, Wu H, Liu Y, Ji P, et al. Prediction model for delirium in patients with cardiovascular surgery: Development and validation. J Cardiothorac Surg. 2022; 17: 247. https://doi.org/10.1186/s13019-022-02005-3
López-Gil JF, García-Hermoso A, Martínez-González MÁ, Rodríguez-Artalejo F. Mediterranean diet and cardiometabolic biomarkers in children and adolescents: A systematic review and meta-analysis. JAMA Netw Open. 2024; 7(7): e2421976 https://doi.org/10.1001/jamanetworkopen.2024.21976
Jensen AE, Søndergaard J, Kjær NK, Nielsen JB. Patients’ views on usefulness and effects of a risk communication tool for cardiovascular disease: A qualitative analysis. BMC PrimCare. 2024; 25: 50. https://doi.org/10.1186/s12875-024-02279-7
Moreira-Rosário A, Ismael S, Barreiros-Mota I, Morais J, Rodrigues C, Castela I, et al. Empowerment-based nutrition interventions on blood pressure: A randomized comparative effectiveness trial. Front Public Health. 2023; 11: 1277355. https://doi.org/10.3389/fpubh.2023.1277355
Liu Z, Thergarajan P, Antonic-Baker A, Chen Z, Sparks PB, Lannin NA, et al. Cardiac structural and functional abnormalities in epilepsy: A systematic review and meta-analysis. Epilepsia Open. 2023; 8: 46-59. https://doi.org/10.1002/epi4.12692
Demandt JPA, Zelis JM, Koks A, Smits GHJM, van der Harst P, Tonino PAL, et al. Prehospital risk assessment in patients suspected of non-ST-segment elevation acute coronary syndrome: A systematic review and meta-analysis. BMJ Open. 2022; 12(4): e057305. https://doi.org/10.1136/bmjopen-2021-057305
Margel D, Ber Y, Peer A, Shavit-Grievink L, Pinthus JH, Witberg G, et al. Cardiac biomarkers in patients with prostate cancer and cardiovascular disease receiving gonadotrophin releasing hormone agonist vs antagonist. Prostate Cancer Prostatic Dis. 2021; 24: 177-185. https://doi.org/10.1038/s41391-020-0264-9
Brotons C, Moral I, Fernández D, Puig M, Vilella MT, Puig T, et al. Effectiveness of an intervention aimed at improving information for patients with high cardiovascular risk: Inforisk clinical trial. Int J Environ Res Public Health. 2021; 18(7): 3621. https://doi.org/10.3390/ijerph18073621
Patterson K, Davey R, Keegan R, Freene N. Smartphone applications for physical activity and sedentary behaviour change in people with cardiovascular disease: A systematic review and meta-analysis. Plos One. 2021; 16(10): e0258460. https://doi.org/10.1371/journal.pone.0258460
Ellahi B, Aitken A, Dikmen D, Seyhan-Erdo?an B, Makda M, Razaq R. Acceptability, usability and weight loss outcomes in a randomized cross-over study of commercially available portion size tools in an overweight South Asian community. Int J Environ Res Public Health. 2022; 19(13): 7714. https://doi.org/10.3390/ijerph19137714
Bragg AE, Crowe-White KM, Ellis AC, Studer M, Phillips F, Samsel S, et al. Changes in cardiometabolic risk among older adults with obesity: An Ancillary analysis of a randomized controlled trial investigating exercise plus weight maintenance and exercise plus intentional weight loss by caloric restriction. J Acad Nutr Diet. 2022; 122(2): 354-362. https://doi.org/10.1016/j.jand.2021.07.009
Murphy L, Sherifali D, Ali MU, Ibrahim S. Influence of diabetes mellitus on oncological outcomes for patients living with cancer. Sci Diabetes Self Manag Care. 2023; 49(2): 163-179. https://doi.org/10.1177/26350106231153073
Vakhshoori M, Nemati S, Sabouhi S, Shakarami M, Yavari B, Emami SA, et al. Prognostic impact of monocyte-to-lymphocyte ratio in coronary heart disease: A systematic review and meta-analysis. J Int Med Res. 2023; 51(10). https://doi.org/10.1177/03000605231204469
Besora-Moreno M, Llauradó E, Valls RM, Tarro L, Pedret A, Solà R. Antioxidant-rich foods, antioxidant supplements, and sarcopenia in old-young adults ?55 years old: A systematic review and meta-analysis of observational studies and randomized controlled trials. Clin Nutr. 2022; 41(10): 2308-2324. https://doi.org/10.1016/j.clnu.2022.07.035
von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP. The strengthening the reporting of observational studies in epidemiology (Strobe) statement: Guidelines for reporting observational studies. Ann Intern Med. 2007; 147(8): 573-577. https://doi.org/10.7326/0003-4819-147-8-200710160-00010
Ahmad OM, Ibrahim R, Odunsi DI, Mohammed M, Mathew BG, Touny M, et al. Role of mobile health and wearable devices in cardiovascular disease prevention: A comprehensive review. Cureus. 2025; 17(5): e83673. https://doi.org/10.7759/cureus.83673
Qi Y, Mohamad E, Azlan AA, Zhang C, Ma Y, Wu A. Digital health solutions for cardiovascular disease prevention: Systematic review. J Med Internet Res. 2025; 27: e64981. https://doi.org/10.2196/64981
Sarwar CMS, Vaduganathan M, Anker SD, Coiro S, Papadimitriou L, Saltz J, et al. Mobile health applications in cardiovascular research. Int J Cardiol. 2018; 269: 265-271. https://doi.org/10.1016/j.ijcard.2018.06.039
Bertolazzi A, Quaglia V, Bongelli R. Barriers and facilitators to health technology adoption by older adults with chronic diseases: An integrative systematic review. BMC Public Health. 2024; 24(1): 506. https://doi.org/10.1186/s12889-024-18036-5
Shao Y, Yang X, Chen Q, Guo H, Duan X, Xu X, et al. Determinants of digital health literacy among older adult patients with chronic diseases: a qualitative study. Front Public Health. 2025; 13: 1568043. https://doi.org/10.3389/fpubh.2025.1568043
Hepburn J, Williams L, McCann L. Barriers to and facilitators of digital health technology adoption among older adults with chronic diseases: Updated systematic review. JMIR Aging. 2025; 8: e80000. https://doi.org/10.2196/80000
Reimer LM, Nissen L, von Scheidt M, Perl B, Wiehler J, Najem SA, et al. User-centered development of an mHealth app for cardiovascular prevention. Digital Health. 2024; 10. https://doi.org/10.1177/20552076241249269
Almutairi M, Almutairi AA, Alodhialah AM. The influence of lifestyle modifications on cardiovascular outcomes in older adults: Findings from a cross-sectional study. Life. 2025; 15(1): 87. https://doi.org/10.3390/life15010087
Pedretti RF, Asteggiano R, Gevaert AB, Bowen TS, Caselli S, Cornelissen VA, et al. Cardiovascular risk factors management in older adults: A clinical consensus statement from the European Association of Preventive Cardiology of the ESC and the ESC Council for Cardiology Practice. Eur J Prev Cardiol. 2025: zwaf175. https://doi.org/10.1093/eurjpc/zwaf175
de Souza Ferreira E, de Aguiar Franco F, Dos Santos Lara MM, Levcovitz AA, Dias MA, Moreira TR, et al. The effectiveness of mobile application for monitoring diabetes mellitus and hypertension in the adult and elderly population: Systematic review and meta-analysis. BMC Health Serv Res. 2023; 23: 855. https://doi.org/10.1186/s12913-023-09879-6
Liu K, Xie Z, Or CK. Effectiveness of mobile app-assisted self-care interventions for improving patient outcomes in type 2 diabetes and/or hypertension: systematic review and meta-analysis of randomized controlled trials. JMIR mHealth uHealth. 2020; 8(8): e15779. https://doi.org/10.2196/15779
Kuan PX, Chan WK, Ying DKF, Rahman MAA, Peariasamy KM, Lai NM, et al. Efficacy of telemedicine for the management of cardiovascular disease: A systematic review and meta-analysis. Lancet Digit Health. 2022; 4(9): e676-e691. https://doi.org/10.1016/S2589-7500(22)00124-8
Zupa MF, Vimalananda VG, Rothenberger SD, Lin JY, Ng JM, McCoy RG, et al. Patterns of telemedicine use and glycemic outcomes of endocrinology care for patients with type 2 diabetes. JAMA Netw Open. 2023; 6(12): e2346305. https://doi.org/10.1001/jamanetworkopen.2023.46305
Vimalananda VG, Brito JP, Eiland LA, Lal RA, Maraka S, McDonnell ME, et al. Appropriate use of telehealth visits in endocrinology: policy perspective of the endocrine society. J Clin Endocrinol Metab. 2022; 107 (11): 2953-2962. https://doi.org/10.1210/clinem/dgac494
Liang F, Yang X, Peng W, Zhen S, Cao W, Li Q, et al. Applications of digital health approaches for cardiometabolic diseases prevention and management in the Western Pacific region. Lancet Reg Health – West Pac. 2024; 43: 100817. https://doi.org/10.1016/j.lanwpc.2023.100817
Goswami A, Poole L, Thorlu-Bangura Z, Khan N, Hanif W, Khunti K, et al. The use of digital health interventions for cardiometabolic diseases among South Asian and black minority ethnic groups: Realist review. J Med Internet Res. 2023; 25: e40630. https://doi.org/10.2196/40630
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Copyright (c) 2026 Revista Colombiana de Endocrinología, Diabetes & Metabolismo